Peripheral blood mononuclear cell GPSM2 levels might be a new marker for prognosis of patients with hepatocellular carcinoma stage III

Yu Zhe, Luo Jing, Yang Yongping

Journal of Practical Hepatology . 2021, (4): 556 -560 . DOI: 10.3969/j.issn.1672-5069.2021.04.026